BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 10989694)

  • 1. The presence or absence of ribonucleotide reductase activity has no affect on avirulent bovine herpesvirus 2.
    Germano SJ; May JT
    Acta Virol; 2001 Feb; 45(1):65-6. PubMed ID: 11394581
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolation of a thymidine kinase-deficient bovine herpesvirus 2 that still causes disease.
    Handley A; Puclin J; May JT
    Aust Vet J; 1996 Aug; 74(2):158-9. PubMed ID: 8894027
    [No Abstract]   [Full Text] [Related]  

  • 3. Vaccination against bovine herpes mammillitis virus infections in guinea pigs.
    Smee DF; Leonhardt JA
    Intervirology; 1994; 37(1):20-4. PubMed ID: 7928285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An acute outbreak of teat lesions affecting 38% of a dairy herd in Northland.
    Petrovski KR
    N Z Vet J; 2005 Apr; 53(2):162-3. PubMed ID: 15846404
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bovine herpes mammillitis: clinical symptoms and serologic course].
    Janett F; Stäuber N; Schraner E; Stocker H; Thun R
    Schweiz Arch Tierheilkd; 2000 Jul; 142(7):375-80. PubMed ID: 11008514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of prophylactic vaccines for genital and neonatal herpes.
    Jones CA; Cunningham AL
    Expert Rev Vaccines; 2003 Aug; 2(4):541-9. PubMed ID: 14711338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of thymidine kinase activity in a potential bovine herpesvirus 2 vaccine does not increase its virulence.
    Paxman JJ; Enriquez AM; May JT
    Acta Virol; 2000 Feb; 44(1):57-9. PubMed ID: 10989694
    [No Abstract]   [Full Text] [Related]  

  • 8. Animal vaccination and the evolution of viral pathogens.
    Schat KA; Baranowski E
    Rev Sci Tech; 2007 Aug; 26(2):327-38. PubMed ID: 17892155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resiquimod: a new immune response modifier with potential as a vaccine adjuvant for Th1 immune responses.
    Wu JJ; Huang DB; Tyring SK
    Antiviral Res; 2004 Nov; 64(2):79-83. PubMed ID: 15498602
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.